Literature DB >> 19910726

Health advisories and patterns of patient monitoring among new users of antidepressant medications.

Joshua J Gagne1, Amanda R Patrick, Philip S Wang, Sebastian Schneeweiss.   

Abstract

INTRODUCTION: In 2003, more intense monitoring of patients initiating antidepressants was advised because of emerging concerns of suicidality. We sought to identify patterns of patient monitoring after antidepressant initiation in British Columbia before and after issuance of health advisories.
MATERIALS AND METHODS: We conducted a cohort study of antidepressant initiators between 1999 and 2005 using healthcare utilization data of all British Columbia residents. For the periods before (1999-2001) and after (2004-2005), health advisories concerning suicidality associated with antidepressants, we assessed monitoring intensity by calculating weekly physician and psychotherapy visit rates since antidepressant initiation. We also estimated monitoring patterns as the proportion of individuals who received weekly in-person contact during the first 4 weeks of treatment, then biweekly visits for 4 weeks, and then a visit at 12 weeks, as a proxy for intensive monitoring.
RESULTS: Patterns of monitoring intensity were similar before and after the health advisories, but the level of intensity was lower after the advisory period. Overall, monitoring intensity peaked in the 4 weeks after antidepressant initiation. Weekly numbers of visits per subject during these 4 weeks were between 0.44 and 0.49 before the advisory and from 0.39 to 0.44 after the advisory. Among all initiators stratified by year of initiation, between 21% and 25% received intensive monitoring, and this proportion generally decreased on a yearly basis. DISCUSSION: Monitoring intensity for patients with depression initiating antidepressants decreased after the period of emergence and greater awareness of the association between antidepressants and suicidality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910726      PMCID: PMC2905672          DOI: 10.1097/JCP.0b013e3181bf4eb9

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

1.  Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001-2004.

Authors:  Richard M Martin; Margaret May; David Gunnell
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

2.  Frequency of follow-up care for adult and pediatric patients during initiation of antidepressant therapy.

Authors:  Glen D Stettin; Jianying Yao; Robert R Verbrugge; Robert E Aubert
Journal:  Am J Manag Care       Date:  2006-08       Impact factor: 2.229

3.  Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.

Authors:  Arif Khan; Shirin Khan; Russell Kolts; Walter A Brown
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

4.  The effect of antidepressant warnings on prescribing trends in Ontario, Canada.

Authors:  Paul A Kurdyak; David N Juurlink; Muhammad M Mamdani
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

5.  Assessing the Saskatchewan database for outcomes research studies of depression and its treatment.

Authors:  S L West; A Richter; C A Melfi; M McNutt; M E Nennstiel; J A Mauskopf
Journal:  J Clin Epidemiol       Date:  2000-08       Impact factor: 6.437

6.  Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.

Authors:  Elaine H Morrato; Anne M Libby; Heather D Orton; Frank V Degruy; David A Brent; Richard Allen; Robert J Valuck
Journal:  Am J Psychiatry       Date:  2007-11-06       Impact factor: 18.112

7.  Suicidality in pediatric patients treated with antidepressant drugs.

Authors:  Tarek A Hammad; Thomas Laughren; Judith Racoosin
Journal:  Arch Gen Psychiatry       Date:  2006-03

8.  Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Authors:  Laurence Y Katz; Anita L Kozyrskyj; Heather J Prior; Murray W Enns; Brian J Cox; Jitender Sareen
Journal:  CMAJ       Date:  2008-04-08       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.